Foundation News
Meet the 2021-2022 Oncology Fellow – Melanie Degliuomini, MD, MS
This year, Melanie Degliuomini, MD, MS, was named the Kristen Ann Carr Fund Medical Oncology Fellow at Memorial Sloan Kettering Cancer Center (MSK) for 2021-22. Dr. Degliuomini is a third-year pediatric fellow in the combined Memorial Sloan Kettering Cancer Center (MSK) and NYPWeill Cornell Medicine (WCMC) program. Dr. Degliuomini’s primary clinical and research focus has…
Read MoreCatch up with 2019-2020 KACF Medical Oncology Fellow Tara O’Donohue
Dr. O’Donohue is currently a Clinical Instructor in the Department of Pediatrics at MSK Kids focusing on developmental therapeutics in relapsed and refractory childhood cancers. Cancers that occur in the pediatric population are a heterogeneous group of relatively uncommon malignancies with complex and understudied biologic characteristics, often resulting in a lack of effective therapeutic options.…
Read MoreMeet the new KACF Fellow – Madalyn G. Neuwirth
Dr. Madalyn Neuwirth is the 2020 – 2021 KACF Surgical Fellow and is completing her second year as a Complex General Surgical Oncology Fellow at Memorial Sloan Kettering Cancer Center with plans to pursue an academic surgical oncology career in treating soft tissue sarcoma patients. She is currently involved in clinical outcomes research for soft…
Read MoreCOVID-19: What You Should Know
It’s hard to stay calm when the world is upside down. This is particularly true for people going through cancer, who are especially vulnerable to infection. Fortunately, there are tips and tools for how to cope from our partners at Memorial Sloan Kettering. #StaySafeStayHome How can I protect myself from getting COVID-19? You can protect…
Read More2019 Kristen Ann Carr Fund Holiday Letter
Dear Family, Friends, Colleagues and Supporters, Happy Holidays to all! We are heading into our 27th year in our fight against sarcoma. All those years ago Kristen asked Dr. Murray Brennan, her physician and then chief of surgery at MSKCC and a sarcoma expert, “what do you need”? Murray responded that we need surgeons and…
Read MoreFROM THE KACF SARCOMA LAB AT MEMORIAL SLOAN KETTERING
Support from the Kristen Ann Carr Fund (KACF) will fully fund Memorial Sloan Kettering Cancer Center (MSK) senior research technician Lei Zhang, PhD, as she works to uncover the genes that drive the development of rare sarcomas in children and young adults. Using state-of-the-art genetic sequencing and the genome-editing tool CRISPR-Cas9, Dr. Zhang and her…
Read MoreTeam KACF Rides Again: 6th Year Participating in Cycle for Survival
Cycle for Survival, which ranks as the fastest growing athletic fundraiser in the country, attracted 31,000 participants in 16 cities across the United States and internationally. Equinox Clubs, which hosts the rides propelled Cycle for Survival to reach an incredible $200 million! It takes a movement powered by a fierce and dedicated community to reach…
Read More2018 A Record-Breaking Year!
Our 25th Anniversary Gala last April 21st was another amazing A Night to Remember. Hosted by Barbara Carr, Dave Marsh and Sasha Carr, Kristen’s legacy was front and center as the evening was shared with many longtime supporters and new friends. Over 400 guests dined on the always exceptional cuisines from Tribeca Grill, NOBU, Batard,…
Read More2018 Kristen Ann Carr Fund Holiday Letter
Dear Friends, This letter is our annual message to those who have, for the past 25 years, been our collaborators in creating The Kristen Ann Carr Fund. The letter serves as a report on what we’re planning, a compilation of memories of what’s already been done in Kristen’s name, and a description and assessment…
Read MoreSarcoma Research Led by Aimee Crago, MD, PhD
Ongoing support from the Kristen Ann Carr Fund (KACF) to Memorial Sloan Kettering Cancer Center (MSK) is funding critical research in the laboratory of Aimee Crago, MD, PhD, a surgeon specializing in soft tissue sarcomas. Surgical removal of well- and de-differentiated liposarcomas is almost universally followed by an aggressive recurrence of these cancers. Systemic treatments,…
Read More